TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine trial offers hope for vulnerable patients in dengue zones
⭐️ VACCINE ⭐️ Not yet recruitingThis study is testing whether a single-dose dengue vaccine is safe and works well for people with autoimmune diseases like rheumatoid arthritis or lupus. Researchers will compare about 320 patients with these conditions to 160 healthy volunteers, all living in areas where dengue …
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial aims to halt scarring in rare blood vessel disease
Disease control Not yet recruitingThis study is testing if adding the drug pirfenidone to standard treatment can better control Takayasu arteritis, a rare disease that causes scarring and narrowing of blood vessels. Researchers will compare pirfenidone to a placebo in 92 patients already on standard therapy to se…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for rare, severe blood vessel disease as trial tests promising drug
Disease control Not yet recruitingThis study is testing if a drug called secukinumab can help control severe Takayasu arteritis, a rare disease that causes dangerous inflammation in the body's largest blood vessels. It will involve 52 patients with active, severe disease to see if the drug can achieve remission a…
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC